Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Patton Boggs" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Patton Boggs for you to read. Along with our medical data and news we also list Patton Boggs Clinical Trials, which are updated daily. BioPortfolio also has a large database of Patton Boggs Companies for you to search.
Leerink Revelation Partners (LRP), an investment partnership formed in 2015 between Leerink Capital Partners and Revelation Partners to provide capital and liquidity solutions to healthcare investors, funds, founders and companies, announced the closing of a second fund focused on secondary investments in healthcare. The new fund, Leerink Revelation Health...
San Francisco-based private financial group hosts lively event exploring the fall of health technology company Theranos and how it could have been prevented. SAN FRANCISCO (PRWEB) May 17, 2018 On May 3rd, US Capital Global hosted a well-attended, open event exploring the downfall of Theranos, the highly valued, “revolutionary” blood-testing company charged with securities fraud by the U.S. Se...
RadSite™, a Centers for Medicare and Medicaid Services (CMS)-recognized accreditation organization promoting quality-based imaging, is seeking candidates to serve on its Advisory Board, Accreditation Committee and Standards Committee. ANNAPOLIS, Md. (PRWEB) May 08, 2018 Committees Support RadSite’s Quality Benchmarking Activities for Diagnostic Imaging RadSite™, a Centers for Medicare and M...
The PODD teams bring to the West Coast a Drug Delivery Design & Partnering Meeting. This inaugural program focuses on meeting the design needs of drug delivery systems from the perspectives of pharma, physicians, patients, investors, as well as KOLs in personalized medicine and digital. NEW YORK (PRWEB) March 16, 2018 The Conference Forum is pleased to bring the inaugural Drug Delivery Design...
SAN FRANCISCO, CA--(Marketwired - March 08, 2018) - Dance Biopharm Holdings Inc. ("Dance"), a privately-held biotechnology company focused on the development of Dance 501, a proprietary 'soft-mist' inhaled insulin product to treat diabetes, is pleased to announce the appointment of Benjamin Wolin to its board of directors. Wolin was co-founder and CEO of Everyday Health (NYSE: EVDY), the leading ...
Fintan Walton talks to John Patton, CSO and Co-founder of Nektar Therapeutics about the challenges he faced in setting up the firm and the company’s success to date. John describes how his research at Genentech on inhaled proteins prompted him to set up Nektar (then Inhale Therapeutic Systems), and discusses the resistance he faced from traditional players in the diabetes market when seeking par...